Pulling SEC filings + quote and writing the call…

Amerant Bancorp Inc.
Next earnings Jul 21, 2026 · consensus $0.40 EPS, $101M rev
Last earnings +1.5% on 2026-04-23
Post-restructuring Florida community bank trading at 19.7x earnings on a normalizing book — fair, not cheap.
Diluted EPS $1.26 · FY2025
Middling fundamentals offset by an attractive price (~85% below fair value) — worth a look on the value angle.
Amerant is a Coral Gables-based community bank that just executed a meaningful strategic reset. FY2025 net income recovered to $52.4M ($1.26 diluted EPS) from a $15.8M loss in FY2024, and management used the year to shed structural drag: per the MD&A, the company is winding down Amerant Mortgage (FTE cut from 77 to 3 by year-end 2025, full wind-down expected 1H 2026) and dissolving the Cayman Bank, refocusing on its 21 South Florida and 2 Tampa banking centers. That refocus is the right strategic move, and it explains the earnings snap-back — but it also means FY2025 results contain non-recurring noise from the transitions.
The balance sheet tells a more sobering story. Total assets shrank 1.3% to $9.78B, cash dropped 20.4% to $470M, and liabilities/equity sits at 9.41x — typical for a bank but offering little room for error. ROE of 5.6% is well below the ~10-12% threshold investors should expect from a healthy community bank, suggesting FY2025 earnings are still depressed relative to a normalized run-rate. The four-year net income trajectory ($113M → $63M → $32M → -$16M → $52M) shows volatility, not durability. The 2021 sale-leaseback of the headquarters (18-year term) and the fact that 77% of the HQ building is now leased to third parties or vacant signals an ongoing real-estate overhang.
Is AMTB a buy? The one-page verdict, explained →
HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $113M | $63.3M | $32.5M | -$15.8M | $52.4M |
| Diluted EPS | $3.01 | $1.85 | $0.96 | -$0.44 | $1.26 |
| Net margin | — | — | — | — | — |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Amendment to prior 8-K; clarifying detail, no new material info.
Shelf registration filed; capacity to issue equity/debt — potential dilution risk.
Annual meeting vote results disclosed; routine governance update.
Officer/director change announced; leadership transition continues.
Reg FD disclosure with exhibits; investor communication, no material change.
Another officer change paired with Reg FD update; ongoing management churn.
Q1'26 10-Q; balance sheet stable at ~$9.8B assets, earnings momentum continues.
Q1'26 earnings release; follow-through on FY25 rebound to $52.4M net income.
Sources: SEC EDGAR (CIK 0001734342, latest 10-Q filed 2026-05-01) · EODHD · Proprietary analysis · as of 6/25/2026, 2:29:48 PM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 25, 2026, 10:29 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2026-06-17 | Nursey Michael E. See remarks | Exercise | 1.34K | |
| 2026-06-17 | Nursey Michael E. See remarks | Tax | 328.00 @ $23.23 | $7.62K |
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.